TY  - JOUR
TT  - Matrıx Metalloproteınase-9 Expressıon In Natural Infected Dogs Wıth Parvovırus
AU  - Karayiğit, Mehmet Önder
AU  - Karataş, Özhan
PY  - 2018
DA  - March
JF  - Sağlık Bilimleri Dergisi
JO  - JHS
PB  - Erciyes University
WT  - DergiPark
SN  - 1018-3655
SP  - 60
EP  - 63
VL  - 27
IS  - 1
KW  - Parvoviral enteritis
KW  - MMP-9
KW  - köpek
N2  - Canine parvoviral enteritis has, since its emergence in 1978, been common in young dogs. After ingestion, the virus attacks rapidly dividing cells in the intestinal tract and bone marrow, causing severe vomiting, diarrhoea, fever, rapid dehydration, lethargy and decreased activity. MMPs are crucial for embryonic development, differentiation, proliferation, and regeneration of tissues. An imbalance between MMPs activating and inhibiting factors, however, results in a plethora of diseases including intestinal inflammation, arthritis, atherosclerosis or cancer. Importantly, expression levels of MMP-9 is upregulated in intestinal inflammation models and in patients suffering from human inflammatory bowel diseases such as Crohn’s disease or ulcerative colitis. The aim of this study is to investigate the role of MMP-9 in the intestinal infection of dogs with parvovirus. In this study, intestinal tissues of 21 dog naturally infected with parvovirus were stained with MMP-9 antibody and five normal healty dog tissues were used as control. As a result, MMP-9 expression from intestinal tissues of dogs with parvovirus-infected occurred while control tissues did not expression. These results indicate that MMP-9 expression might have an impact on the pathogenesis of parvovirus-induced enteritis in dogs.
CR  - 1. Decaro N, Desario C, Addie DD, et al. The study
molecular epidemiology of canine parvovirus.
Europe Emerg Infect Dis 2007;13:1222–1224.
CR  - 2. Hoelzer K, Shackelton LA, Parrish CR, et al.  Phylogenetic analysis reveals the emergence,
evolution and dispersal of carnivore parvoviruses. J
Gen Virol 2008;89:2280–2289.
CR  - 3. Macintire DK, Smith-Carr S. Canine parvovirus. Part
II. Clinical signs, diagnosis, and treatment. Comp
Cont Educ Prac 1997; 19: 291-302.
CR  - 4. Turk J, Miller M, Brown T, et al. Coliform septicemia
and pulmonary disease associated with canine
parvoviral enteritis: 88 cases (1987-1988). J Am Vet
Med Assoc 1990;196: 771-773.
CR  - 5. Meunier PC, Cooper BJ, Appel MJ, et al. Pathogenesis
of canine parvovirus enteritis: The importance of
viremia. Vet Pathol 1985;22:60–71.
CR  - 6. Goetzl EJ, Banda MJ, Leppert D. Matrix
metalloproteinases in immunity. J Immunol
1996;156:1–4.
CR  - 7. B r i n c k e r h o f f C E , M a t r i s i a n L M .
Matrixmetalloproteinases: a tail of a frog that
became a prince. Nat Rev Mol Cell Biol 2002; 3:207–
214.
CR  - 8. Birkedal-Hansen H, Moore WG, Bodden MK, et al.
Matrixmetalloproteinases: a review. Crit Rev Oral
Biol Med 1993;4:197–250.
CR  - 9. Nelson AR, Fingleton B, Rothenberg ML, et al.
Matrixmetalloproteinases:biologic activity and
clinical implications. J Clin Oncol 2000; 18:1135–
1149.
CR  - 10. William CS, Carole L, Wilson S, et al. Matrix
metalloproteinases as modulators of inflammation
and innate immunity. Immonology 2014; 4:617-629
CR  - 11. Salmela MT, MacDonald TT, Black D, et al.
Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the intestinal:
analysis by genearray and in situ hybridisation.
İntestinal 2002; 51:540–547.
CR  - 12. Munoz M, Heimesaat MM, Danker K, et al.
Interleukin (IL)-23 mediates Toxoplasma gondii
induced immunopathology in the intestinal via
matrixmetalloproteinase- 2 and IL-22 but
independent of IL-17. J Exp Med 2009;206:3047–
3059.
CR  - 13. Heimesaat MM, Dunay IR, Fuchs D, et al. The distinct
roles of MMP-2 and MMP-9 in acute DSS colitis. Eur J
Microbiol Immunol (Bp) 2011; 1:302–310.
CR  - 14. von LB, Barthel B, Coupland SE, et al. Differential
expression of matrix metalloproteinases and their
tissue inhibitors in colon mucosa of patients with
inflammatory bowel disease. İntestinal 2000; 47:63–
73.
CR  - 15. Meijer MJ, Mieremet-Ooms MA, van der Zon AM, et
al. Increased mucosal matrix metalloproteinase-1, -
2, -3 and −9 activity in patients with inflammatory
bowel disease and the relation with Crohn's disease
phenotype. Dig Liver Dis 2007; 39:733–739.
CR  - 16. Pender SL, Li CK, Di Sabatino A, et al. Role of
macrophage metalloelastase in intestinal
inflammation. Ann N Y Acad Sci 2006; 1072:386–
388.
CR  - 17. Santana A, Medina C, Paz-Cabrera MC, et al.
Attenuation of dextran sodium sulphate induced
colitis in matrix metalloproteinase-9 deficient mice.
World J Gastroenterol 2006; 12:6464–6472.
CR  - 18. David MR, Andrew JS, Steve PH, et al. Matrix
metalloproteinase 9 contributes to intestinal
microbe homeostasis in a model of infectious colitis.
BMC Microbiol 201212:105.
CR  - 19. Bailey CJ, Hembry RM, Alexander A, et al.
Distribution of the matrix metalloproteinases
stromelysin, gelatinasesA and B, and collagenase in
Crohn’s disease and normal intestine. J Clin Pathol
199447:113–116.
CR  - 20. Baugh MD, Perry MJ, Hollander AP, et al. Matrix
metalloproteinase levels are elevated in
inflammatory bowel disease. Gastroenterology
1999; 117:814–822.
CR  - 21. Louis E, Ribbens C, Godon A, et al. Increased
production ofmatrixmetalloproteinase-3 and tissue
inhibitor of metalloproteinase-1 by inflamed mucosa
in inflammatory bowel disease. Clin Exp Immunol
2000; 120:241–246.
CR  - 22. Hongchun L, Neal RP, Lewins W, et al. Constitutive
expression of MMP9 in intestinal epithelium
worsens murine acute colitis and is associated with
increased levels of proinflammatory cytokine Kc.
Am J Physiol Gastrointest Liver Physiol 2013;
304:793–803.
CR  - 23. Marie EA, Ursula G, André F, et al. The role of
gelatinases in campylobacter jejuni infection of
gnotobiotic mice. Eur J Microbiol Immunol 2015;
4:256–267.
CR  - 24. Crawford HC, Matrisian LM. Mechanisms controlling
the transcription of matrixmetalloproteinase genes
in normal and neoplastic cells. Enzyme Protein
1996; 49:20–37.
CR  - 25. Saren P, Welgus HG, Kovanen PT. TNF-alpha and IL1beta selectively induce expression of 92-kDa
gelatinase by human macrophages. J Immunol
1996;157:4159–4165.
UR  - https://dergipark.org.tr/en/pub/eujhs/issue//553206
L1  - https://dergipark.org.tr/en/download/article-file/694077
ER  -